Anticoagulants, Procoagulants, Fibrinolytics



The haemostatic profile of 46 healthy, adult female llamas was evaluated and compared to a human reference plasma. The results indicate that standard laboratory reagents and procedures are suitable for the determination of procoagulant, anticoagulant and fibrinolytic analytes in llama plasma. Human recombinant tissue factor is an effective reagent for the prothrombin time assay. With this reagent, llama plasma exhibited a clotting time similar to human reference plasma. The activated partial thromboplastin time results were shorter for llama plasma than for human plasma, and there was a significant (p<0.05) increase, in the order of tenfold, in factor VIII:C activity when human plasma was used as the reference standard. The activities of other procoagulant proteins, including factor VII, IX, X and Xl, were similar irrespective of whether llama or human reference standards were used.

The anticoagulant or inhibitory activity, as determined by the amounts of α2-macroglobulin and antithrombin, the fibrinolytic activity, as estimated from the levels of plasminogen and plasminogen activators, as well as fibrinogen values are consistent with those reported for other domestic species such as the horse.

Comments

Post a Comment

Popular posts from this blog

Antimycobacterial Agents

Image
Historically, mycobacterial infections have been associated with signifi cant morbidity and mortality worldwide. In particular, Mycobacterium tuberculosis is a highly successful human pathogen, infecting one-third of the world’s population and leading to approximately 3 million deaths worldwide annually (1). The organism is unique in its ability to establish persistent infection, requiring prolonged treatment with antimicrobials in order to achieve clinical cure. In general, the goals of antituberculosis therapy include rapid reduction of the massive numbers of actively multiplying bacilli in the diseased host, prevention of acquired drug resistance, and sterilization of infected host tissues to prevent clinical relapse. In order to achieve these goals, currently accepted guidelines recommend administration of multiple active drugs for a minimum duration of 6 months (2). In areas where drug resistance is prevalent and resources permit, M. tuberculosis clinical isolates should be
Read more

Antibacterials

Image
Antibacterial: Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home. Cultures and antibiotic sensitivity testing are essential for selecting a drug for serious infections. However, treatment must often begin before culture results are available, necessitating selection according to the most likely pathogens (empiric antibiotic selection). Whether chosen according to culture results or not, drugs with the narrowest spectrum of activity that can control the infection should be used. For empiric treatment of serious infections that may involve any on
Read more

Pharmacologic Treatment of Dyslipidemia

Image
Dyslipidemias are disorders of lipoprotein metabolism, including lipoprotein overproduction or deficiency. These disorders may be manifested by elevation of the serum total cholesterol, low-density lipoprotein (LDL) cholesterol and triglyceride concentrations, and a decrease in the high-density lipoprotein (HDL) cholesterol concentration. Epidemiologic, angiographic and postmortem studies have documented a causal relationship between elevated serum cholesterol levels and the genesis of coronary heart disease. Angiographic studies show that aggressive cholesterol reduction by a variety of methods, as opposed to dietary modifications alone, results in increased rates of plaque regression and stabilization. Treatment with cholesterol-lowering drugs appears to be accompanied by a reduction in the lipid content of atherosclerotic plaques, thereby making them more stable and less prone to rupture. The Scandinavian Simvastatin Survival Study demonstrated a 30 percent reduction in t
Read more